therapies

Several clinical trials are already investigating whether disease-modifying therapies can benefit people who have biological signs of Alzheimer's but have not yet experienced cognitive impairment.

From Science Daily ● Oct. 31, 2026

Treatments have been advancing, including more targeted therapies for early breast cancer, new types of hormonal therapies, and more precise and effective radiotherapy.

From BBC ● Oct. 24, 2026

This ongoing challenge has encouraged scientists to explore additional approaches that could complement existing therapies.

From Science Daily ● Oct. 24, 2026

But the most up-to-date data shows that the hazard ratio didn’t degrade much over time, which commonly happens after experimental therapies move from smaller Phase 2 trials into larger Phase 3 studies.

From MarketWatch ● Oct. 23, 2026

This means pharmaceutical companies, scientists, and universities control what research can be done on those genes, and how much resulting therapies and diagnostic tests will cost.

From "The Immortal Life of Henrietta Lacks" by Rebecca Skloot